Posterior subcapsular cataract formation as a risk of steroid therapy is generally assumed to be much lower with inhaled steroids than with systemic steroids. In this study, slit-lamp examinations were done on 14 adult asthmatic patients who were taking inhaled steroids (beclomethasone diproprionate) combined with intermittant short reducing cour¬ses of oral steroids. The mean age of the patients was 39.289+2.99 (SEM), the mean cur¬rent daily dose of inhaled steroid was 1089.29+106.80 (SEM) ug and the mean duration of inhaled steroid therapy was 46.79+2.85 (SEM) months. The prevalence of posterior sub¬capsular cataracts was 7.14%. Genel olarak, inhale steroid kullanan hastalarda, posterior subkapsüler katarakt gelişme riskinin sistemik steroid kullananlara göre daha az olduğu düşünülmektedir. Bu çalışmada, gerektiğinde kısa süreli oral steroid tedavisi de alan ve inhale steroid (beklometazon diproprinat) kullanmakta bulunan 14 erişkin astmatik hasta posterior subkapsüler katarakt gelişimi açısından incelendi. Hastaların yaş ortalaması 39.29±2.99 uM, günlük inhale steroid dozu ortalaması 1089.29+106.80 mg ve inhale steroid kullanım süresi orta¬laması 46.79±2.85 ay idi. Posterior subkapsüler katarakt prevanlansı %7.14 olarak bulun¬du.